Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Ayala Pharmaceuticals, Inc.
| Metric | Ayala Pharmaceuticals, Inc. ADXSHealthcare |
|---|---|
| Quality Score | 25 / 100 |
| Revenue (latest) | $13,000 |
| Net income (latest) | −$48M |
| Operating margin | −278969.2% |
| Net margin | −369784.6% |
| Return on equity | 196.9% |
| Return on assets | −290.0% |
| Return on capital (ROCE) | — |
| Debt / equity | — |
| Revenue growth (YoY) | −94.8% |
| Altman Z″ (distress) | — |
| Accruals / assets | −112.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.